Work

Artesunate–mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial

Year: 2015

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Infectious Diseases

DOI: 10.1016/s1473-3099(15)00415-6

Authors: Matthew J Grigg, Timothy William, Jayaram Menon, Prabakaran Dhanaraj, Bridget E Barber, Christopher S Wilkes, Lorenz von Seidlein, Giri S Rajahram, Cielo Pasay, James S McCarthy, Ric N Price, Nicholas M Anstey, Tsin W Yeo

Institutions: The University of Queensland, Charles Darwin University, Menzies School of Health Research, Queen Elizabeth Hospital, Queen Elizabeth Hospital, QIMR Berghofer Medical Research Institute, University of Oxford, Nanyang Technological University, Tan Tock Seng Hospital, National Centre for Infectious Diseases

Language: English

Topic: Malaria Research and Control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Wellcome Trust, Menzies School of Health Research

Award: Optimising antimalarial combination therapies in an area coendemic for vivax and falciparum malaria

OpenAlex ID: W2202698629

FWCI: 9.262

Cites: 27

Cited by: 66

Related to: 10